Literature DB >> 15921778

Carvedilol improves left ventricular function in murine coxsackievirus-induced acute myocarditis association with reduced myocardial interleukin-1beta and MMP-8 expression and a modulated immune response.

Matthias Pauschinger1, Susanne Rutschow, Kumaran Chandrasekharan, Dirk Westermann, Anneke Weitz, Lothar Peter Schwimmbeck, Heinz Zeichhardt, Wolfgang Poller, Michel Noutsias, Jun Li, Heinz-Peter Schultheiss, Carsten Tschope.   

Abstract

BACKGROUND: Proinflammatory cytokines induce the expression of matrix metalloproteinases that play a crucial role in myocardial remodeling. Beta-adrenergic receptor stimulation influences the production of cytokines heralding the possibility of modulating cytokine production by beta-adrenergic blockers. METHODS AND
RESULTS: In a coxsackievirus B3 murine myocarditis model (BALB/c), effects of carvedilol and metoprolol on myocardial cytokine expression, inflammatory cell infiltration and MMP/TIMP profiles were investigated. In carvedilol-treated mice, a significant improvement in left ventricular function was documented 10 days post infection. In infected mice (n=10), IL-1beta, TNF-alpha, TGF-beta(1) and IL-10 myocardial mRNA abundance were increased significantly (240%, 200%, 161%, and 230%) compared to controls (n=10), while IL-15 mRNA was markedly reduced (70%). Infected mice showed significantly increased infiltrations with CD3-, CD4- and CD8-T-lymphocytes (730%, 1110%, 380%). In the infected mice, myocardial MMP/TIMP profiles presented a significant upregulation of membrane type-1 MMP, MMP-9, MMP-8 and MMP-3 (150%, 160%, 340%, and 270%) and a significant decrease in TIMP-4 levels (75%). Carvedilol attenuated over-expression of myocardial TGF-beta(1), IL-1beta and MMP-8 mRNA expression significantly and induced a relevant IL-10 mRNA expression in the infected mice (n=10). By an unchanged infiltration with CD3-T-lymphocytes, carvedilol showed a representative reduction in CD4-T-lymphocytes.
CONCLUSION: Carvedilol treatment in experimental myocarditis leads to reduced expression of proinflammatory cytokines and MMPs, which contributes to reduced matrix degradation and ultimately to improved structural integrity of the heart. Besides the antiadrenergic potential, carvedilol is beneficial due to a wide range of biological activities (antiinflammatory, antifibrotic, antioxidative and immunomodulatory).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15921778     DOI: 10.1016/j.ejheart.2004.07.002

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  18 in total

Review 1.  The relationship between the MMP system, adrenoceptors and phosphoprotein phosphatases.

Authors:  A Rietz; Jp Spiers
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

Review 2.  Pathogenesis of chagas' disease: parasite persistence and autoimmunity.

Authors:  Antonio R L Teixeira; Mariana M Hecht; Maria C Guimaro; Alessandro O Sousa; Nadjar Nitz
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

3.  Correlations of the changes in bioptic findings with echocardiographic, clinical and laboratory parameters in patients with inflammatory cardiomyopathy.

Authors:  Jan Krejci; Petr Hude; Hana Poloczkova; Vita Zampachova; Radka Stepanova; Tomas Freiberger; Eva Nemcova; Lenka Spinarova
Journal:  Heart Vessels       Date:  2014-12-25       Impact factor: 2.037

Review 4.  Inflammation, ECG changes and pericardial effusion: whom to biopsy in suspected myocarditis?

Authors:  M Pauschinger; M Noutsias; D Lassner; H-P Schultheiss; U Kuehl
Journal:  Clin Res Cardiol       Date:  2006-08-16       Impact factor: 5.460

Review 5.  Translating Koch's postulates to identify matrix metalloproteinase roles in postmyocardial infarction remodeling: cardiac metalloproteinase actions (CarMA) postulates.

Authors:  Rugmani Padmanabhan Iyer; Lisandra E de Castro Brás; Yu-Fang Jin; Merry L Lindsey
Journal:  Circ Res       Date:  2014-02-28       Impact factor: 17.367

Review 6.  Matrix metalloproteinases: drug targets for myocardial infarction.

Authors:  Andriy Yabluchanskiy; Yaojun Li; Robert J Chilton; Merry L Lindsey
Journal:  Curr Drug Targets       Date:  2013-03       Impact factor: 3.465

7.  Antimicrobial agents for myocarditis: target the pathway, not the pathogen.

Authors:  Lori A Blauwet; Leslie T Cooper
Journal:  Heart       Date:  2009-07-16       Impact factor: 5.994

Review 8.  Matrix metalloproteinase-9: Many shades of function in cardiovascular disease.

Authors:  Andriy Yabluchanskiy; Yonggang Ma; Rugmani Padmanabhan Iyer; Michael E Hall; Merry L Lindsey
Journal:  Physiology (Bethesda)       Date:  2013-11

9.  Mesenchymal stromal cells but not cardiac fibroblasts exert beneficial systemic immunomodulatory effects in experimental myocarditis.

Authors:  Konstantinos Savvatis; Sophie van Linthout; Kapka Miteva; Kathleen Pappritz; Dirk Westermann; Joerg C Schefold; Gerhard Fusch; Alice Weithäuser; Ursula Rauch; Peter-Moritz Becher; Karin Klingel; Jochen Ringe; Andreas Kurtz; Heinz-Peter Schultheiss; Carsten Tschöpe
Journal:  PLoS One       Date:  2012-07-17       Impact factor: 3.240

Review 10.  Advancements in the diagnostic workup, prognostic evaluation, and treatment of takotsubo syndrome.

Authors:  Muhammad Ali; Angelos G Rigopoulos; Khaldoun Ali; Ignatios Ikonomidis; George Makavos; Marios Matiakis; Hannes Melnyk; Elena Abate; Mammad Mammadov; Jan Lukas Prüser; Renato de Vecchis; Walter Wohlgemuth; Athanassios Manginas; Boris Bigalke; Sophie Mavrogeni; Daniel Sedding; Michel Noutsias
Journal:  Heart Fail Rev       Date:  2020-09       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.